Corrigendum to “Structure–activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures” [Bioorg. Med. Chem. 23 (2015) 1601–1612](S0968089615000735)(10.1016/j.bmc.2015.01.049)

Shannon L. Nowotarski, Boobalan Pachaiyappan, Steven L. Holshouser, Craig J. Kutz, Youxuan Li, Yi Huang, Shiv K. Sharma, Robert A. Casero, Patrick M. Woster

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Fingerprint Dive into the research topics of 'Corrigendum to “Structure–activity study for (bis)ureidopropyl- and (bis)thioureidopropyldiamine LSD1 inhibitors with 3-5-3 and 3-6-3 carbon backbone architectures” [Bioorg. Med. Chem. 23 (2015) 1601–1612](S0968089615000735)(10.1016/j.bmc.2015.01.049)'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences